Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
51ºÚÁϳԹÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Review of Infliximab Therapy in Chronic Inflammatory Diseases: Mechanisms and Clinical Outcomes
Infliximab, a chimeric monoclonal antibody targeting tumor necrosis factor-alpha (TNF-α), has revolutionized the treatment landscape of chronic inflammatory diseases. This review comprehensively explores the mechanisms of action, therapeutic indications, and clinical outcomes associated with Infliximab therapy across various conditions.... Read More»
: J Pulm Res Dis 2024
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, 51ºÚÁϳԹÏÍø Journals